Fundraising Fox
🦊/People
Sign in

Nessan Bermingham

InvestorFounder

Operator at Khosla Ventures · Mr. Bermingham is the Executive Chair of the Issuer. at Korro Bio · Founder at Intellia Therapeutics

Jackson, Wyoming, United States

FoundedIntellia TherapeuticsKorro Bio

Find your path to Nessan

391 people in our graph share verified history with Nessan — schools, employers, funds. One of them is your warm intro.

Dan LynchunlockedNessan: together at Xilio Therapeutics (2020)
×9Nessan: together at Khosla Ventures
Nessan: together at Atlas Venture
Nessan: together at F-star Therapeutics, Inc.

About

Nessan Bermingham is an operating partner at Khosla Ventures with nearly three decades of experience in life sciences. He has founded and led multiple biotech companies focused on gene editing, RNA therapeutics, and cell therapies, including Intellia Therapeutics, which went public within two years of its founding. His investment experience spans public and private equities, debt instruments, and cross-border healthcare transactions.

Mr. Bermingham is the Executive Chair of the Issuer. at Korro Bio

Intro paths

→

In turn, Nessan can intro founders to Korro Bio's investors below.

Korro Bio's investors · 8

AlexandriaPasadena · since 2020Atlas VentureCambridge · $500K – $1M checks · since 2019MC Healthcare VenturesCambridge · since 2019New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2019Qiming Venture Partners USACambridge · since 2020Rock Springs CapitalBaltimore · since 2024Taiwania CapitalTaipei · $3M – $85M checks · since 2019Wu Capitalsince 2020

Co-founders at Korro Bio

JFJean-François Formela
Jean-François FormelaDirector

Founder at Intellia Therapeutics

Intro paths

→

In turn, Nessan can intro founders to Intellia Therapeutics's investors below.

Intellia Therapeutics's investors · 7

age1San Francisco · $500K – $4M checks · since 2015Atlas VentureCambridge · $500K – $1M checks · since 2015Avoro Capital AdvisorsNew York · since 2015EcoR1 CapitalSan Francisco · since 2015Fidelity InvestmentsBoston · since 2015Foresite CapitalWest Hollywood · since 2015OrbiMedNew York · $1M – $75M checks · since 2015

Co-founders at Intellia Therapeutics

JD
Jennifer DoudnaCo-founder

Experience

  1. Khosla VenturesOperating Partnercurrent2021 — presentCambridge, Massachusetts, United States
  2. Biotechnology Innovation OrganizationVice Chair BIO Investor Councilcurrent2026 — present
  3. D2B3Investor & Board Membercurrent2026 — presentNew Haven, Connecticut, United States
  4. Excelsior SciencesInvestor & Board Membercurrent2025 — presentNew York, New York, United States
  5. Amide TechnologiesBoard Membercurrent2025 — presentWaltham, Massachusetts, United States
  6. Kamau TherapeuticsInvestor & Board Membercurrent2024 — presentSouth San Francisco, California, United States
  7. Eligo BioscienceBoard Membercurrent2024 — presentParis, Île-de-France, France
  8. Stylus MedicineInvestor & Board Membercurrent2024 — presentCambridge, Massachusetts, United States
  9. Ochre BioBoard Membercurrent2022 — presentCambridge, England, United Kingdom
  10. Liberate BioFounder, Investor & Board Membercurrent2022 — presentCambridge, Massachusetts, United States
  11. EveryONE MedicinesFounder & Board Membercurrent2022 — presentBoston, Massachusetts, United States
  12. Deep GenomicsBoard Membercurrent2022 — presentToronto Canada
  13. Korro Bio, Inc.Founder & Exec Chaircurrent2018 — presentCambridge, Massachusetts, United States
  14. F-star Therapeutics, Inc.Chairperson2018 — 2023
  15. Triplet TherapeuticsFounder, CEO & Exec Chair2018 — 2022
  16. Atlas VentureVenture Partner2018 — 2020
  17. Xilio Therapeutics, Inc.Exec Chair2018 — 2020
  18. Intellia Therapeutics, Inc.Founder, President & CEO2014 — 2017
  19. Atlas VentureEIR2012 — 2014
  20. Omega FundsPartner2007 — 2008

Skills & more

Board GovernanceBoard LevelFundraisingEntrepreneurshipLife SciencesPortfolio ManagementMolecular BiologyAnalytical SkillsBusinessBiotechnologyFinancial AnalysisVenture Capital1
+8 moreBusiness FormationBiotechnology IndustryExec ChairIPOMergers & Acquisitions (M&A)FinancingsBusiness StrategyBusiness Development

From Nessan's professional profile.

Colleagues at Khosla Ventures

Adina Tecklu
Investor at Khosla Ventures
Adrian Radu
Investor at Khosla Ventures
Alex Morgan
Investor at Khosla Ventures
Alice Brooks
Investor at Khosla Ventures
Amy Kalokerinos
Investor at Khosla Ventures
Anne Foor
Investor at Khosla Ventures
Austin Hay
Investor at Khosla Ventures
Avisha Mehra Naganath
Investor at Khosla Ventures

Frequently asked questions

Who is Nessan Bermingham?
Nessan Bermingham is an operating partner at Khosla Ventures with nearly three decades of experience in life sciences. He has founded and led multiple biotech companies focused on gene editing, RNA therapeutics, and cell therapies, including Intellia Therapeutics, which went public within two years of its founding. His investment experience spans public and private equities, debt instruments, and cross-border healthcare transactions.
Where does Nessan Bermingham work?
Nessan Bermingham is Founder of Intellia Therapeutics and Operator at Khosla Ventures and Mr. Bermingham is the Executive Chair of the Issuer. at Korro Bio.
What companies did Nessan Bermingham found?
Nessan Bermingham founded Intellia Therapeutics, Korro Bio.
Where did Nessan Bermingham go to school?
Nessan Bermingham studied at Baylor College of Medicine (Post doctoral research - Howard Hughes Assoc Fellow); Imperial College London (Doctor of Philosophy - PhD, Molecular Biology); Queen's University Belfast (Bachelor's degree, Genetics).

Founder mafias

Same school

Shared employers